These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14972084)

  • 21. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
    Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive pharmacogenetics.
    Nogueira JB
    Rev Port Cardiol; 2004 Dec; 23(12):1621-30. PubMed ID: 15732663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms and pharmacogenetic signals underlying thiazide diuretics blood pressure response.
    Shahin MH; Johnson JA
    Curr Opin Pharmacol; 2016 Apr; 27():31-7. PubMed ID: 26874237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomics of antihypertensive drugs: past, present and future.
    Johnson JA
    Pharmacogenomics; 2010 Apr; 11(4):487-91. PubMed ID: 20350127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genes and hypertension.
    Garcia EA; Newhouse S; Caulfield MJ; Munroe PB
    Curr Pharm Des; 2003; 9(21):1679-89. PubMed ID: 12871201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension?
    Arnett DK; Claas SA; Lynch AI
    Curr Opin Cardiol; 2009 Jul; 24(4):333-9. PubMed ID: 19509486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic mapping and tailored antihypertensive therapy.
    Ferrari P; Bianchi G
    Cardiovasc Drugs Ther; 2000 Aug; 14(4):387-95. PubMed ID: 10999645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics of human hypertension, the role of angiotensinogen. should it be one of the drug target genes?
    Kolovou GD; Mavrogeni S
    Angiology; 2014 Apr; 65(4):269-71. PubMed ID: 23719091
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene-environment interactions of selected pharmacogenes in arterial hypertension.
    Bochud M; Guessous I
    Expert Rev Clin Pharmacol; 2012 Nov; 5(6):677-86. PubMed ID: 23234325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses.
    Turner ST; Boerwinkle E
    Pharmacogenomics; 2003 Jan; 4(1):53-65. PubMed ID: 12517286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers.
    Höcht C; Bertera FM; Mayer MA; Taira CA
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):199-211. PubMed ID: 20095790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics, ancestry, and hypertension: implications for targeted antihypertensive therapies.
    Franceschini N; Chasman DI; Cooper-DeHoff RM; Arnett DK
    Curr Hypertens Rep; 2014 Aug; 16(8):461. PubMed ID: 24903233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics of hypertension.
    Cadman PE; O'Connor DT
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):61-70. PubMed ID: 12496668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertension pharmacogenomics: in search of personalized treatment approaches.
    Cooper-DeHoff RM; Johnson JA
    Nat Rev Nephrol; 2016 Feb; 12(2):110-22. PubMed ID: 26592190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide association studies of hypertension: have they been fruitful?
    Rafiq S; Anand S; Roberts R
    J Cardiovasc Transl Res; 2010 Jun; 3(3):189-96. PubMed ID: 20560039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
    McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA
    Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphisms.
    Hamrefors V; Sjögren M; Almgren P; Wahlstrand B; Kjeldsen S; Hedner T; Melander O
    J Hypertens; 2012 Jun; 30(6):1151-60. PubMed ID: 22525200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics of hypertension and heart disease.
    Arwood MJ; Cavallari LH; Duarte JD
    Curr Hypertens Rep; 2015 Sep; 17(9):586. PubMed ID: 26272307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistant hypertension: Core Curriculum 2008.
    Parker MG
    Am J Kidney Dis; 2008 Oct; 52(4):796-802. PubMed ID: 18706748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.